Biotechnology Jobs

• Stevenage
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late pre-candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• Stevenage
• Director

Leads Quantitative Systems Pharmacology and QST modelling within GSK's Clinical Pharmacology and Quantitative Medicine group, building mechanistic mathematical models of disease, drug action and trial design. Defines clinical pharmacology strategy across the Respiratory, Immunology and Inflammation portfolio, working with biologists, clinicians, statisticians and AI/ML colleagues. The role sits in a newly formed Centre of Excellence for Model-Informed Drug Development, initially in Stevenage with a planned move to Cambridge.

• Oxford
• Hybrid
• Senior
• Permanent

Builds and operates high-performance GPU training and inference clusters, focusing on scheduling, isolation and automated lifecycle management. Optimises high-throughput data paths, I/O, caching and Lustre storage, and profiles bottlenecks across compute, network and orchestration layers. Works with research and data teams on capacity planning, quotas and ML experimentation pipelines.

Lustre

• Waltham, United States
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

• Stevenage
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

• Zug, Switzerland
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

• London
• Hybrid · 2 days in office
• US$202,500 – US$371,250 pa
• Director · manages people

Leads clinical development strategy for hepatology assets within GSK's Respiratory, Immunology & Inflammation Research Unit, from target identification through proof-of-concept studies. Accountable for clinical matrix team leadership, protocol design, medical monitoring and regulatory interactions across all development phases. Hybrid role with at least two on-site days weekly.

• Boston, United States
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director · manages people

Leads clinical development strategy for hepatology assets within the Respiratory, Immunology & Inflammation Research Unit, overseeing study design, medical monitoring, and regulatory interactions. Accountable for the Clinical Matrix Team, target validation, translational plans, and Go/No Go decision criteria across early-phase programs. Hybrid role requiring on-site presence at least two days per week.

• Stevenage
• Hybrid · 2 days in office
• US$202,500 – US$371,250 pa
• Director · manages people

Leads clinical development strategy for hepatology assets within the Respiratory, Immunology & Inflammation Research Unit, identifying next-generation liver disease targets and progressing them to proof-of-concept. Accountable for clinical development plans, study protocols, medical monitoring and safety governance, and chairs the Clinical Matrix Team. Hybrid role with at least two days per week on-site.

• Waltham, United States
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase clinical development programs in GSK's Respiratory, Immunology & Inflammation Research Unit, focusing on aging. Leads the Clinical Matrix Team, designs clinical development plans and study protocols, oversees medical monitoring and safety, and represents programs in regulatory interactions. Works cross-functionally with biology, translational sciences, commercial, and regulatory partners.

• Stevenage
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across translational and clinical studies within GSK's Respiratory, Immunology & Inflammation Research Unit, with a focus on aging. Leads a Clinical Matrix Team, designs clinical development plans and protocols, and oversees medical monitoring, safety and regulatory interactions. Hybrid working with at least two days per week on-site, initially in Stevenage before a planned relocation to Cambridge, UK.

• London
• Hybrid · 2 days in office
• US$189,750 – US$316,250 pa
• Director · manages people

Provides clinical and scientific leadership across early-phase clinical development programs in GSK's Respiratory, Immunology & Inflammation Research Unit, with a focus on aging research. Leads a Clinical Matrix Team, designs clinical development plans and study protocols, oversees medical monitoring and safety, and represents programs in regulatory interactions. Works cross-functionally with biology, translational sciences, commercial, regulatory and statistics partners.

• Stevenage
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

AI/ML

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory approval and initial launch. Acts as senior clinical representative at governance forums and leads cross-functional collaboration across research, precision medicine, medical affairs and commercial in a global matrix.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.